Global HIV Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
According to our (Global Info Research) latest study, the global HIV Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global HIV Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HIV Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HIV Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HIV Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
HIV Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe HIV Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HIV Therapy, with price, sales, revenue and global market share of HIV Therapy from 2018 to 2023.
Chapter 3, the HIV Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HIV Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HIV Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of HIV Therapy.
Chapter 14 and 15, to describe HIV Therapy sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global HIV Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global HIV Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HIV Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HIV Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HIV Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HIV Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
HIV Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Integrase Inhibitors
- Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Combination HIV Medicines
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- ViiV Healthcare
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Bristol-Myers Squibb Company
- Janssen Pharmaceuticals, Inc.
- Boehringer Ingelheim International GmbH
- AbbVie Inc.
- Genentech, Inc.
- Mylan N.V.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe HIV Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HIV Therapy, with price, sales, revenue and global market share of HIV Therapy from 2018 to 2023.
Chapter 3, the HIV Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HIV Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HIV Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of HIV Therapy.
Chapter 14 and 15, to describe HIV Therapy sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of HIV Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HIV Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Integrase Inhibitors
1.3.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.3.4 Combination HIV Medicines
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global HIV Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.4.5 Others
1.5 Global HIV Therapy Market Size & Forecast
1.5.1 Global HIV Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HIV Therapy Sales Quantity (2018-2029)
1.5.3 Global HIV Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare HIV Therapy Product and Services
2.1.4 ViiV Healthcare HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ViiV Healthcare Recent Developments/Updates
2.2 Gilead Sciences, Inc.
2.2.1 Gilead Sciences, Inc. Details
2.2.2 Gilead Sciences, Inc. Major Business
2.2.3 Gilead Sciences, Inc. HIV Therapy Product and Services
2.2.4 Gilead Sciences, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences, Inc. Recent Developments/Updates
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc HIV Therapy Product and Services
2.3.4 GlaxoSmithKline Plc HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Plc Recent Developments/Updates
2.4 Merck Sharp & Dohme Corp.
2.4.1 Merck Sharp & Dohme Corp. Details
2.4.2 Merck Sharp & Dohme Corp. Major Business
2.4.3 Merck Sharp & Dohme Corp. HIV Therapy Product and Services
2.4.4 Merck Sharp & Dohme Corp. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Sharp & Dohme Corp. Recent Developments/Updates
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company HIV Therapy Product and Services
2.5.4 Bristol-Myers Squibb Company HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.6 Janssen Pharmaceuticals, Inc.
2.6.1 Janssen Pharmaceuticals, Inc. Details
2.6.2 Janssen Pharmaceuticals, Inc. Major Business
2.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Product and Services
2.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
2.7 Boehringer Ingelheim International GmbH
2.7.1 Boehringer Ingelheim International GmbH Details
2.7.2 Boehringer Ingelheim International GmbH Major Business
2.7.3 Boehringer Ingelheim International GmbH HIV Therapy Product and Services
2.7.4 Boehringer Ingelheim International GmbH HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.8 AbbVie Inc.
2.8.1 AbbVie Inc. Details
2.8.2 AbbVie Inc. Major Business
2.8.3 AbbVie Inc. HIV Therapy Product and Services
2.8.4 AbbVie Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Inc. Recent Developments/Updates
2.9 Genentech, Inc.
2.9.1 Genentech, Inc. Details
2.9.2 Genentech, Inc. Major Business
2.9.3 Genentech, Inc. HIV Therapy Product and Services
2.9.4 Genentech, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Genentech, Inc. Recent Developments/Updates
2.10 Mylan N.V.
2.10.1 Mylan N.V. Details
2.10.2 Mylan N.V. Major Business
2.10.3 Mylan N.V. HIV Therapy Product and Services
2.10.4 Mylan N.V. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan N.V. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIV THERAPY BY MANUFACTURER
3.1 Global HIV Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global HIV Therapy Revenue by Manufacturer (2018-2023)
3.3 Global HIV Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HIV Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HIV Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 HIV Therapy Manufacturer Market Share in 2022
3.5 HIV Therapy Market: Overall Company Footprint Analysis
3.5.1 HIV Therapy Market: Region Footprint
3.5.2 HIV Therapy Market: Company Product Type Footprint
3.5.3 HIV Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HIV Therapy Market Size by Region
4.1.1 Global HIV Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global HIV Therapy Consumption Value by Region (2018-2029)
4.1.3 Global HIV Therapy Average Price by Region (2018-2029)
4.2 North America HIV Therapy Consumption Value (2018-2029)
4.3 Europe HIV Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific HIV Therapy Consumption Value (2018-2029)
4.5 South America HIV Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa HIV Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global HIV Therapy Sales Quantity by Type (2018-2029)
5.2 Global HIV Therapy Consumption Value by Type (2018-2029)
5.3 Global HIV Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HIV Therapy Sales Quantity by Application (2018-2029)
6.2 Global HIV Therapy Consumption Value by Application (2018-2029)
6.3 Global HIV Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America HIV Therapy Sales Quantity by Type (2018-2029)
7.2 North America HIV Therapy Sales Quantity by Application (2018-2029)
7.3 North America HIV Therapy Market Size by Country
7.3.1 North America HIV Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America HIV Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe HIV Therapy Sales Quantity by Type (2018-2029)
8.2 Europe HIV Therapy Sales Quantity by Application (2018-2029)
8.3 Europe HIV Therapy Market Size by Country
8.3.1 Europe HIV Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe HIV Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific HIV Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HIV Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HIV Therapy Market Size by Region
9.3.1 Asia-Pacific HIV Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HIV Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America HIV Therapy Sales Quantity by Type (2018-2029)
10.2 South America HIV Therapy Sales Quantity by Application (2018-2029)
10.3 South America HIV Therapy Market Size by Country
10.3.1 South America HIV Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America HIV Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HIV Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HIV Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HIV Therapy Market Size by Country
11.3.1 Middle East & Africa HIV Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HIV Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 HIV Therapy Market Drivers
12.2 HIV Therapy Market Restraints
12.3 HIV Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HIV Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of HIV Therapy
13.3 HIV Therapy Production Process
13.4 HIV Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HIV Therapy Typical Distributors
14.3 HIV Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of HIV Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HIV Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Integrase Inhibitors
1.3.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.3.4 Combination HIV Medicines
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global HIV Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.4.5 Others
1.5 Global HIV Therapy Market Size & Forecast
1.5.1 Global HIV Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HIV Therapy Sales Quantity (2018-2029)
1.5.3 Global HIV Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare HIV Therapy Product and Services
2.1.4 ViiV Healthcare HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ViiV Healthcare Recent Developments/Updates
2.2 Gilead Sciences, Inc.
2.2.1 Gilead Sciences, Inc. Details
2.2.2 Gilead Sciences, Inc. Major Business
2.2.3 Gilead Sciences, Inc. HIV Therapy Product and Services
2.2.4 Gilead Sciences, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences, Inc. Recent Developments/Updates
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc HIV Therapy Product and Services
2.3.4 GlaxoSmithKline Plc HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Plc Recent Developments/Updates
2.4 Merck Sharp & Dohme Corp.
2.4.1 Merck Sharp & Dohme Corp. Details
2.4.2 Merck Sharp & Dohme Corp. Major Business
2.4.3 Merck Sharp & Dohme Corp. HIV Therapy Product and Services
2.4.4 Merck Sharp & Dohme Corp. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Sharp & Dohme Corp. Recent Developments/Updates
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company HIV Therapy Product and Services
2.5.4 Bristol-Myers Squibb Company HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.6 Janssen Pharmaceuticals, Inc.
2.6.1 Janssen Pharmaceuticals, Inc. Details
2.6.2 Janssen Pharmaceuticals, Inc. Major Business
2.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Product and Services
2.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
2.7 Boehringer Ingelheim International GmbH
2.7.1 Boehringer Ingelheim International GmbH Details
2.7.2 Boehringer Ingelheim International GmbH Major Business
2.7.3 Boehringer Ingelheim International GmbH HIV Therapy Product and Services
2.7.4 Boehringer Ingelheim International GmbH HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.8 AbbVie Inc.
2.8.1 AbbVie Inc. Details
2.8.2 AbbVie Inc. Major Business
2.8.3 AbbVie Inc. HIV Therapy Product and Services
2.8.4 AbbVie Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Inc. Recent Developments/Updates
2.9 Genentech, Inc.
2.9.1 Genentech, Inc. Details
2.9.2 Genentech, Inc. Major Business
2.9.3 Genentech, Inc. HIV Therapy Product and Services
2.9.4 Genentech, Inc. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Genentech, Inc. Recent Developments/Updates
2.10 Mylan N.V.
2.10.1 Mylan N.V. Details
2.10.2 Mylan N.V. Major Business
2.10.3 Mylan N.V. HIV Therapy Product and Services
2.10.4 Mylan N.V. HIV Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan N.V. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIV THERAPY BY MANUFACTURER
3.1 Global HIV Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global HIV Therapy Revenue by Manufacturer (2018-2023)
3.3 Global HIV Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HIV Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HIV Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 HIV Therapy Manufacturer Market Share in 2022
3.5 HIV Therapy Market: Overall Company Footprint Analysis
3.5.1 HIV Therapy Market: Region Footprint
3.5.2 HIV Therapy Market: Company Product Type Footprint
3.5.3 HIV Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HIV Therapy Market Size by Region
4.1.1 Global HIV Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global HIV Therapy Consumption Value by Region (2018-2029)
4.1.3 Global HIV Therapy Average Price by Region (2018-2029)
4.2 North America HIV Therapy Consumption Value (2018-2029)
4.3 Europe HIV Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific HIV Therapy Consumption Value (2018-2029)
4.5 South America HIV Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa HIV Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global HIV Therapy Sales Quantity by Type (2018-2029)
5.2 Global HIV Therapy Consumption Value by Type (2018-2029)
5.3 Global HIV Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HIV Therapy Sales Quantity by Application (2018-2029)
6.2 Global HIV Therapy Consumption Value by Application (2018-2029)
6.3 Global HIV Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America HIV Therapy Sales Quantity by Type (2018-2029)
7.2 North America HIV Therapy Sales Quantity by Application (2018-2029)
7.3 North America HIV Therapy Market Size by Country
7.3.1 North America HIV Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America HIV Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe HIV Therapy Sales Quantity by Type (2018-2029)
8.2 Europe HIV Therapy Sales Quantity by Application (2018-2029)
8.3 Europe HIV Therapy Market Size by Country
8.3.1 Europe HIV Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe HIV Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific HIV Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HIV Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HIV Therapy Market Size by Region
9.3.1 Asia-Pacific HIV Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HIV Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America HIV Therapy Sales Quantity by Type (2018-2029)
10.2 South America HIV Therapy Sales Quantity by Application (2018-2029)
10.3 South America HIV Therapy Market Size by Country
10.3.1 South America HIV Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America HIV Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HIV Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HIV Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HIV Therapy Market Size by Country
11.3.1 Middle East & Africa HIV Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HIV Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 HIV Therapy Market Drivers
12.2 HIV Therapy Market Restraints
12.3 HIV Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HIV Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of HIV Therapy
13.3 HIV Therapy Production Process
13.4 HIV Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HIV Therapy Typical Distributors
14.3 HIV Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global HIV Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HIV Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Major Business
Table 5. ViiV Healthcare HIV Therapy Product and Services
Table 6. ViiV Healthcare HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ViiV Healthcare Recent Developments/Updates
Table 8. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc. Major Business
Table 10. Gilead Sciences, Inc. HIV Therapy Product and Services
Table 11. Gilead Sciences, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences, Inc. Recent Developments/Updates
Table 13. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Plc Major Business
Table 15. GlaxoSmithKline Plc HIV Therapy Product and Services
Table 16. GlaxoSmithKline Plc HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Plc Recent Developments/Updates
Table 18. Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base and Competitors
Table 19. Merck Sharp & Dohme Corp. Major Business
Table 20. Merck Sharp & Dohme Corp. HIV Therapy Product and Services
Table 21. Merck Sharp & Dohme Corp. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Sharp & Dohme Corp. Recent Developments/Updates
Table 23. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Company Major Business
Table 25. Bristol-Myers Squibb Company HIV Therapy Product and Services
Table 26. Bristol-Myers Squibb Company HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bristol-Myers Squibb Company Recent Developments/Updates
Table 28. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Janssen Pharmaceuticals, Inc. Major Business
Table 30. Janssen Pharmaceuticals, Inc. HIV Therapy Product and Services
Table 31. Janssen Pharmaceuticals, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 33. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 34. Boehringer Ingelheim International GmbH Major Business
Table 35. Boehringer Ingelheim International GmbH HIV Therapy Product and Services
Table 36. Boehringer Ingelheim International GmbH HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 38. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Inc. Major Business
Table 40. AbbVie Inc. HIV Therapy Product and Services
Table 41. AbbVie Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AbbVie Inc. Recent Developments/Updates
Table 43. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Genentech, Inc. Major Business
Table 45. Genentech, Inc. HIV Therapy Product and Services
Table 46. Genentech, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Genentech, Inc. Recent Developments/Updates
Table 48. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 49. Mylan N.V. Major Business
Table 50. Mylan N.V. HIV Therapy Product and Services
Table 51. Mylan N.V. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan N.V. Recent Developments/Updates
Table 53. Global HIV Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global HIV Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global HIV Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in HIV Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and HIV Therapy Production Site of Key Manufacturer
Table 58. HIV Therapy Market: Company Product Type Footprint
Table 59. HIV Therapy Market: Company Product Application Footprint
Table 60. HIV Therapy New Market Entrants and Barriers to Market Entry
Table 61. HIV Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global HIV Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global HIV Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global HIV Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global HIV Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global HIV Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global HIV Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global HIV Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global HIV Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global HIV Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global HIV Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 120. HIV Therapy Raw Material
Table 121. Key Manufacturers of HIV Therapy Raw Materials
Table 122. HIV Therapy Typical Distributors
Table 123. HIV Therapy Typical Customers
Table 1. Global HIV Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HIV Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Major Business
Table 5. ViiV Healthcare HIV Therapy Product and Services
Table 6. ViiV Healthcare HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ViiV Healthcare Recent Developments/Updates
Table 8. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc. Major Business
Table 10. Gilead Sciences, Inc. HIV Therapy Product and Services
Table 11. Gilead Sciences, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences, Inc. Recent Developments/Updates
Table 13. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Plc Major Business
Table 15. GlaxoSmithKline Plc HIV Therapy Product and Services
Table 16. GlaxoSmithKline Plc HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Plc Recent Developments/Updates
Table 18. Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base and Competitors
Table 19. Merck Sharp & Dohme Corp. Major Business
Table 20. Merck Sharp & Dohme Corp. HIV Therapy Product and Services
Table 21. Merck Sharp & Dohme Corp. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Sharp & Dohme Corp. Recent Developments/Updates
Table 23. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Company Major Business
Table 25. Bristol-Myers Squibb Company HIV Therapy Product and Services
Table 26. Bristol-Myers Squibb Company HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bristol-Myers Squibb Company Recent Developments/Updates
Table 28. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Janssen Pharmaceuticals, Inc. Major Business
Table 30. Janssen Pharmaceuticals, Inc. HIV Therapy Product and Services
Table 31. Janssen Pharmaceuticals, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 33. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 34. Boehringer Ingelheim International GmbH Major Business
Table 35. Boehringer Ingelheim International GmbH HIV Therapy Product and Services
Table 36. Boehringer Ingelheim International GmbH HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 38. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Inc. Major Business
Table 40. AbbVie Inc. HIV Therapy Product and Services
Table 41. AbbVie Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AbbVie Inc. Recent Developments/Updates
Table 43. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Genentech, Inc. Major Business
Table 45. Genentech, Inc. HIV Therapy Product and Services
Table 46. Genentech, Inc. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Genentech, Inc. Recent Developments/Updates
Table 48. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 49. Mylan N.V. Major Business
Table 50. Mylan N.V. HIV Therapy Product and Services
Table 51. Mylan N.V. HIV Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan N.V. Recent Developments/Updates
Table 53. Global HIV Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global HIV Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global HIV Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in HIV Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and HIV Therapy Production Site of Key Manufacturer
Table 58. HIV Therapy Market: Company Product Type Footprint
Table 59. HIV Therapy Market: Company Product Application Footprint
Table 60. HIV Therapy New Market Entrants and Barriers to Market Entry
Table 61. HIV Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global HIV Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global HIV Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global HIV Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global HIV Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global HIV Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global HIV Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global HIV Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global HIV Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global HIV Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global HIV Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America HIV Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America HIV Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America HIV Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America HIV Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa HIV Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa HIV Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa HIV Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa HIV Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa HIV Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa HIV Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa HIV Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa HIV Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 120. HIV Therapy Raw Material
Table 121. Key Manufacturers of HIV Therapy Raw Materials
Table 122. HIV Therapy Typical Distributors
Table 123. HIV Therapy Typical Customers
LIST OF FIGURES
Figure 1. HIV Therapy Picture
Figure 2. Global HIV Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HIV Therapy Consumption Value Market Share by Type in 2022
Figure 4. Integrase Inhibitors Examples
Figure 5. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Examples
Figure 6. Combination HIV Medicines Examples
Figure 7. Others Examples
Figure 8. Global HIV Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global HIV Therapy Consumption Value Market Share by Application in 2022
Figure 10. Hospital Pharmacies Examples
Figure 11. Retail Pharmacies Examples
Figure 12. Online Pharmacies Examples
Figure 13. Others Examples
Figure 14. Global HIV Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global HIV Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global HIV Therapy Sales Quantity (2018-2029) & (K Units)
Figure 17. Global HIV Therapy Average Price (2018-2029) & (US$/Unit)
Figure 18. Global HIV Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global HIV Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of HIV Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 HIV Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 HIV Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 25. North America HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. South America HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 30. Global HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global HIV Therapy Consumption Value Market Share by Type (2018-2029)
Figure 32. Global HIV Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global HIV Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. Global HIV Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 40. United States HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 56. China HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. HIV Therapy Market Drivers
Figure 77. HIV Therapy Market Restraints
Figure 78. HIV Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of HIV Therapy in 2022
Figure 81. Manufacturing Process Analysis of HIV Therapy
Figure 82. HIV Therapy Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. HIV Therapy Picture
Figure 2. Global HIV Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HIV Therapy Consumption Value Market Share by Type in 2022
Figure 4. Integrase Inhibitors Examples
Figure 5. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Examples
Figure 6. Combination HIV Medicines Examples
Figure 7. Others Examples
Figure 8. Global HIV Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global HIV Therapy Consumption Value Market Share by Application in 2022
Figure 10. Hospital Pharmacies Examples
Figure 11. Retail Pharmacies Examples
Figure 12. Online Pharmacies Examples
Figure 13. Others Examples
Figure 14. Global HIV Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global HIV Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global HIV Therapy Sales Quantity (2018-2029) & (K Units)
Figure 17. Global HIV Therapy Average Price (2018-2029) & (US$/Unit)
Figure 18. Global HIV Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global HIV Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of HIV Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 HIV Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 HIV Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 25. North America HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. South America HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa HIV Therapy Consumption Value (2018-2029) & (USD Million)
Figure 30. Global HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global HIV Therapy Consumption Value Market Share by Type (2018-2029)
Figure 32. Global HIV Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global HIV Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. Global HIV Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 40. United States HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 56. China HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America HIV Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America HIV Therapy Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa HIV Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa HIV Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa HIV Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa HIV Therapy Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa HIV Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. HIV Therapy Market Drivers
Figure 77. HIV Therapy Market Restraints
Figure 78. HIV Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of HIV Therapy in 2022
Figure 81. Manufacturing Process Analysis of HIV Therapy
Figure 82. HIV Therapy Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
